Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 1997

View Archived Issues

Lipid peroxidation inhibitors from Gyogyszerkutato Intezet

New antibacterial agents described by Zeneca

Astra describes new topical anesthetics

Inhibitors of 5alpha-reductase prepared by Merck & Co.

P&U discloses inhibitors of enzyme involved in neurodegenerative diseases

Thrombin inhibitors revealed by Merck & Co.

Janssen prepares lubelozole N-oxides

BRL-49653: Profile of a potential new antidiabetic agent

BTS-67582 preclinical and clinical trials results

Agent for gastroparesis in diabetic patients

Studies reported on absorption of the insulin analogue HOE-901

New antidiabetic agent from Japan Tobacco

NN-304, a long-acting insulin analogue in preclinical testing

Skelid introduced in the U.S.

Introduction of Rescriptor in late June

Company profile: Trilex

Guilford's Parkinson's disease diagnostic safe and effective in phase IIb study

Micrologix Biotech enhancin restores activity of vancomycin

Synthelabo and Praecis collaborate on prostate cancer product

Peptidomimetic inhibitors of fungal NMT prepared by Searle

Encouraging interim data from Avicidin trial

Protein repair enzyme may be involved in seizures/neurodegenerative diseases

Chugai MSD to market OTC famotidine in Japan

Pfizer terminates E5 marketing agreement

Physostigmine improves working memory and alters neural activity in volunteers

Retinal protein reduces need for standard drugs in uveitis

Eclipse cleared by FDA to begin clinical trials of PTMR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...